KR20190136834A - Control system of implantable medical device and control method thereof - Google Patents

Abstract

The present invention relates to a system for controlling an implantable medical device and a method for controlling the same. The system comprises an implantable medical device which is implanted in a body and stimulates a specific part in the body; a management terminal which communicates with the implantable medical device through wireless communication to control operation of the implantable medical device; and a management server which is in connection with the management terminal to be able to communicate therewith, applies priorities to each parameter included in condition information of a patient, saves and manages the same, and provides the saved information. Priorities are applied to each parameter in the condition information of the patient, and stimulation applied to a specific part in the body is adjusted according to the applied priorities. Accordingly, the entire parameters can be controlled to satisfy preset standard values and keep the condition of the patient stable.

Description

Implantable medical device control system and its control method {CONTROL SYSTEM OF IMPLANTABLE MEDICAL DEVICE AND CONTROL METHOD THEREOF}

The present invention relates to an implantable medical device control system and a control method thereof, and more particularly, to an implantable medical device control system implanted in the body and stimulating a specific part of the body and a control method thereof.

Recently, artificial organs such as pacemakers, cochlear implants, gastric stimulators, spinal cord stimulators, cardiac defibrillators, cardiac pacemakers, insulin pumps, foot drop implants, and deep brains are used to alleviate or treat symptoms of various diseases. Various implantable medical devices such as deep brain stimulation (DBS) have been developed.

Among them, the deep brain stimulation device is an implantable medical device that relieves the symptoms of brain disease by applying electrical stimulation to specific areas or nerves of the brain.

The deep brain stimulation apparatus according to the prior art is composed of an electrode implanted in the brain, a control device implanted in the chest area to generate an electrical stimulation signal, and a connecting line connecting the electrode and the control device.

The controller consists of a microprocessor-based complex electronic circuit, a battery for five years of driving, an RF transceiver for communication with the outside, and specially manufactured titanium for long-term stable operation in vivo. It uses the basic structure of a cardiac pacemaker, which is housed in a (Titanium) case and sealed by laser welding.

Therefore, the deep brain stimulation apparatus according to the prior art is expensive manufacturing cost of the control device, the size is too large, the transplant site is forced to descend to the chest, especially when the battery life is reached within five years must be replaced by a new control device through surgery There was a problem.

In order to solve this problem, Patent Document 1 and Patent Document 2 below disclose a deep brain stimulation device technology to which a wireless power transmission technology is applied.

Patent Literature 1 forms a rotating magnetic field by a rotating magnetic disk provided inside a hat worn by a patient, and generates induced power by an induction coil plate fixed to the lower part of the patient's scalp so as to be combined with the formed rotating magnetic field. A deep brain stimulation device configuration is described that is configured to drive an electrode implanted in a body, and that can correct abnormal motor and sensory functions using power wirelessly supplied from the outside of the human body.

Patent Literature 2 includes an internal device implanted in the scalp and an external device for supplying power to the internal device by a wireless power transmission method, wherein the wireless power transmitter of the external device is externally induced with a magnetic field by the power supplied from the battery. A coil and an external coil include an external magnet wound around, and the wireless power receiver of the internal device includes an internal coil aligned with the external coil so that AC power is formed by a magnetic field induced by the external coil, and an internal magnet wound inside the coil. By combining the external device to the internal device with the external coil and the internal coil aligned as the external magnet is attached to the internal magnet, by combining the wireless power transfer function, semi-permanent ultra-deep brain that does not require reoperation due to battery consumption The stimulation system configuration is described.

Republic of Korea Patent Registration No. 10-0877228 (August 26, 2008) Republic of Korea Patent Registration No. 10-1662594 (October 6, 2016 announcement)

The deep brain stimulation device to which the wireless power transmission technology according to the prior art including Patent Document 1 and Patent Document 2 described above is applied induces electric power in a magnetically induced manner between an external magnetic disk and an induction coil disk and an induction coil plate. Generate and send power to your device.

As a technology for transmitting power wirelessly inside the human body, various methods have been tried until now, and electromagnetic induction method and electromagnetic resonance method and electromagnetic resonance method, which use electromagnetic waves, RF method using radio frequency, There is an ultrasonic method using ultrasonic waves.

The electric power transmission device using electromagnetic induction is composed of a charging matrix for generating charging power using an external power source, and a power receiving module receiving charging power through electromagnetic induction from the charging matrix. Is the closest technique to.

However, as electromagnetic waves are rapidly reduced in the air with distance inversely proportional to the distance squared, power transmission devices using electromagnetic induction are limited to the charging matrix and the power receiving module being used at close distances within a few cm of each other. .

For this reason, the deep brain stimulation device to which the wireless power transmission technology using the electromagnetic induction method according to the prior art is continuously transmitted power from the in vitro device, regardless of the load fluctuations in the in vivo device, the battery of the battery provided in the in vitro device Since power is consumed, there is a problem that power efficiency is lowered.

In addition, in the case of applying an electromagnetic wave type power receiver embedded in the human body, as an antenna for a specific frequency band, malfunction occurs due to EMI (Electromagnetic Interface) interference when external electromagnetic noise using the frequency of the band exists. There was a problem.

In addition, in the electromagnetic wave method, when the transmitting unit generates electromagnetic waves, the receiving unit converts the electromagnetic waves into electric power by using a plurality of rectennas combining an antenna and a rectifier, and transmits the power to a long distance. There was a problem that is harmful to the human body.

In addition, the power transmission apparatus using the radio frequency collects energy of RF having a long propagation distance and supplies power to an electronic device or a sensor. RF exists in air a lot, and its propagation distance has a very wide advantage. However, RF has a low energy density itself or a low energy amount after energy conversion.

The ultrasonic wireless power transmission method uses the piezoelectric effect of the ferroelectric.

In other words, if mechanical force or compressive force is applied to both ends of piezoelectric body, electricity is generated. On the contrary, if electric field is applied, contraction or relaxation displacement occurs. The latter can generate ultrasonic waves, and the former generates ultrasonic waves. Electricity can be generated by pressure.

Therefore, the ultrasonic wireless power transmission method uses the piezoelectric phenomenon to generate ultrasonic waves from the outside and transmit them to the human body, and then an ultrasonic receiver composed of an internal piezoelectric body transmits power by making acoustic energy (ultrasound) into electrical energy. .

Ultrasound is a sound wave, so unlike light, a medium is required to propagate and the transfer speed varies depending on the characteristics of the medium layer.

Since human tissue is 70% water, the rate of ultrasound delivery in the body has a value similar to that of water.

For this reason, ultrasound has been proved to be safe in the medical field and has been applied to patient care and medical devices.

The ultrasonic wave may use wireless power when the acoustic vibration generated from the ultrasonic device vibrates the transmission matching layer with the medium and the piezoelectric mechanical energy is transmitted to the receiving device through the matching layer for oscillating the vibration.

The power transmission apparatus using the ultrasonic wave having such a feature is composed of a transmitting device for generating ultrasonic waves, and a receiving device for receiving the generated ultrasonic waves.

The ultrasonic wave power transmission device may be used in various media such as water or human skin. However, when the transmission device and the reception device are separated from each other by a medium such as water or human skin, the power transmission efficiency between the ultrasonic transmission and reception devices may be increased. There was a problem falling.

Accordingly, there is a demand for the development of a technology capable of supplying power to the internal apparatus wirelessly using ultrasonic waves and preventing a decrease in power transmission efficiency.

On the other hand, the deep brain stimulation device according to the prior art is manufactured to stimulate the brain and nerves in accordance with a preset program from a doctor or manufacturer.

Therefore, the deep brain stimulation device according to the prior art has a limit to properly treat according to the various symptoms and progression for each patient, depending on the experience of the doctor or manufacturer.

Therefore, there is a demand for the development of a technology that can appropriately control the drug and stimulus intensity according to the actual symptoms or progression of the diseased patient to alleviate the symptoms caused by the disease and maximize the therapeutic effect.

Disclosure of Invention An object of the present invention is to solve the problems as described above, and to provide an implantable medical device control system and a control method thereof, which can transmit power wirelessly to a device implanted in the body using ultrasound in vitro. will be.

Another object of the present invention is to prioritize various parameters for determining the symptoms and progression of a patient with a disease, and according to the given priority, the stimulation applied to the dosage, the dosing cycle and specific parts of the body The present invention provides an implantable medical device control system and a control method thereof.

Still another object of the present invention is to control the implantable medical device system and its control system that can alleviate the symptoms of the disease and maximize the therapeutic effect by adjusting the intensity and frequency of stimulating a specific part of the body based on the medication information To provide a way.

In order to achieve the object as described above, the implantable medical device control system according to the present invention is implanted in the body to stimulate a specific part of the body implanted medical device, the implanted medical device and the system in a wireless communication method A management terminal that controls the operation of the implantable medical device by performing communication, and stores and manages by giving priority to each parameter included in the patient's state information and communicatively connected to the management terminal and providing stored information. And a management server, wherein the management terminal controls to adjust a stimulus applied to a specific part of the body in the implantable medical device so as to satisfy a predetermined reference value for all parameters based on the priorities. It is done.

The present invention receives the drug information prescribed to the patient through communication with the power transmitter and the management terminal for transmitting power to the implantable medical device in the body in a wireless power transmission method using ultrasound in vitro, and taking the medication information And a patient terminal for detecting the state information of the patient and transmitting the sensing information to the implantable medical device and the management server, wherein the management terminal includes communication equipment connected to the communication device and detection information received from the patient terminal. And controlling the operation of the implantable medical device in the body based on the inspection information.

The management server divides the parameters included in the patient's status information into a plurality of groups, gives priority to each of the divided groups, analyzes and quantifies the inspection or detection information for each parameter, and According to the analysis information provided by analyzing the information digitized according to the management terminal, the management terminal by using the analysis information provided from the management server to adjust the stimulation by the implantable medical device to keep the patient in a stable state It characterized in that the control to.

The management terminal performs a basic test on the patient's condition by using vital sign information including blood pressure, body temperature, and heart rate among the received patient's state information, and if the test result is normal, irritation is applied to a specific part of the body. It characterized in that the control to adjust.

 In addition, in order to achieve the object as described above, the control method of the implantable medical device control system according to the present invention (a) in the implantable medical device in the implanted power from the power transmitter from the outside in the wireless power transmission method Stimulating a specific part of the body by using the method; (b) prioritizing, storing, and managing each parameter included in the patient's status information in the management server; and (c) the management server in the management terminal. And controlling the implantable medical device to adjust a stimulus applied to a specific part of the body to satisfy a predetermined reference value for all parameters based on the priority.

The present invention is characterized in that it further comprises the step of performing a basic test on the condition of the patient using vital sign information including blood pressure, body temperature, heart rate among the state information of the patient in the management terminal.

The present invention is characterized in that it further comprises the step of changing the priority given through the communication with the management server according to the progress of the disease, the change of symptoms and the patient's request in the management terminal.

As described above, according to the implantable medical device control system according to the present invention and a control method thereof, priority is given to each parameter included in the patient's state information, and according to the assigned priority, By adjusting the applied stimulus, the effect is obtained that the entire parameter can be controlled to satisfy the preset reference value and keep the patient in a stabilized state.

Accordingly, according to the present invention, the effect that the pain or symptoms caused by the disease can be alleviated and the therapeutic effect can be maximized.

And according to the present invention, by adjusting the stimulation in real time according to the state information of the patient, the effect that can increase the time to maintain the stabilized state of the patient to improve the patient's satisfaction.

In addition, according to the present invention, by changing the priority of each parameter according to the progress of the disease, the change of symptoms, the request of the patient, etc., the symptoms caused by the disease are alleviated, the treatment effect is improved, and the patient is kept in a stabilized state. The effect can be obtained.

In addition, according to the present invention, by using the vital sign information including blood pressure, body temperature, heart rate among the state information of the patient to perform a basic test on the condition of the patient, the effect of controlling the stimulation can be obtained according to the test result .

1 is a block diagram of a deep brain stimulation apparatus control system according to an embodiment of the present invention,
2 is an exploded view of the deep brain stimulation device shown in FIG.
Figure 3 is a flow chart illustrating a step-by-step control method of the deep brain stimulation apparatus control system according to an embodiment of the present invention.

Hereinafter, an implantable medical device control system and a control method thereof according to a preferred embodiment of the present invention will be described in detail with reference to the accompanying drawings.

In the present embodiment, a deep brain stimulation apparatus is described among the implantable medical devices, but the present invention is not limited thereto.

That is, the present invention implants a device in the body to stimulate a specific part of the body to relieve or treat the symptoms of various diseases, such as an artificial organ or cochlear implant, gastric stimulator, spinal cord stimulator, cardiac defibrillator, It should be noted that it may be applied to a variety of implantable medical device control systems such as cardiac pacemakers, insulin pumps, and foot drop implants.

In addition, in the present embodiment, it is described that the power is supplied to the deep brain stimulation apparatus by transmitting power wirelessly using the ultrasonic wireless charging method, but the present invention uses not only the ultrasonic wireless charging method but also the electromagnetic wave method or the radio frequency method. May be modified to supply power.

1 is a block diagram of a deep brain stimulation apparatus control system according to a preferred embodiment of the present invention.

Deep brain stimulator control system according to a preferred embodiment of the present invention, as shown in Figure 1, a deep brain stimulator 10 implanted inside the scalp to stimulate the brain and nerves, wireless power transmission using ultrasound in vitro The power transmitter 20 for transmitting power to the deep brain stimulation apparatus 10 in a manner, the management terminal 30 for controlling the driving of the deep brain stimulation apparatus 10, the communication terminal 30 is communicatively connected to the patient It stores and manages the state information of the receiving and receiving the medication information prescribed to the patient through communication with the management server 40 and the management terminal 30 to provide the stored information, and detects the medication information and the patient's condition The patient terminal 50 transmits the sensing information to the deep brain stimulation apparatus 10 and the management server 40.

The power transmitter 20 may be provided as an ultrasonic transducer for converting electrical energy into an ultrasonic signal having a predetermined frequency by receiving commercial power and transmitting the converted ultrasonic signal to the deep brain stimulator 10. have.

To this end, the power transmitter 20 may include a driving controller for converting electrical energy into an ultrasonic signal to generate an ultrasonic signal and to transmit the generated ultrasonic signal.

The power transmitter 20 may be provided with a matching layer for matching the acoustic impedance with the power receiver 11 of the deep brain stimulation apparatus 10 to be described below.

The management terminal 30 receives the operation state information of the deep brain stimulation apparatus 10 and the information detected by the deep brain stimulation apparatus 10 through communication with the deep brain stimulation apparatus 10, and deep brain stimulation apparatus 10 Transmits a control command to operate) and may change or update a program of the deep brain stimulation apparatus 10.

To this end, the management terminal 30 may include a communication unit (not shown) to enable communication with the management server 40 and wireless communication with the deep brain stimulation apparatus 10.

The management terminal 30 checks various information about the drug or the patient's condition prescribed by the doctor in the hospital, prescribes a drug for the patient, and controls the doctor to control the stimulation using the deep brain stimulation device (10) It may be provided as a terminal.

In addition, the management terminal 30 and the management server 40 is also connected to communicate with various test equipment 31 for testing the patient's condition, such as blood pressure or body temperature, electromyography, electrocardiogram, electroencephalogram of the patient, each inspection equipment The test result of (31) can be received in real time.

Accordingly, the management terminal 30 may receive the analysis information analyzed by the management server 40, and change, modify, and update the driving program for driving the deep brain stimulation apparatus 10 according to the received analysis information. .

In addition, the management terminal 30 may control the driving of the power transmitter 20 in the process of transmitting power by the wireless power transmission method.

The management server 40 is connected to the management terminal 30, each test equipment 31 and the patient terminal 50 through a local area network or a mobile communication network.

Thus, the management server 40 classifies each parameter included in the management terminal 30 and the status information of the patient received from each test equipment 31 and the patient terminal 50 into a plurality of groups, each group or Priority may be given to the parameters, and control may be performed to maintain the patient's state by satisfying a predetermined reference value for all parameters according to the assigned priority.

For example, Table 1 is a parameter table associated with Parkinson's disease patients.

group parameter Measurement / detection method Drug Information Group Prescribed medication information,
Medication taking information,
Food, Health Food Intake Information Management terminal
Patient terminal
Patient terminal Biometric information group Blood pressure, body temperature, heart rate, etc. Inspection equipment, detection sensor Symptom Information Group Symptoms such as pain and trembling Management terminal, patient terminal EEG Information Group EKG, EKG, EMG, etc. Inspection equipment, detection sensor Pedestrian information group Walk, turn, walk freeze information Inspection equipment, patient terminal Environmental information group Environment change information Inspection equipment, patient terminal Autonomic information group Sleep time, sleep state Inspection equipment, detection sensor Exercise information group Exercise time in daily life,
Inactivity Time Information Inspection equipment, patient terminal Other disease information group Pain caused by other diseases,
Symptom Information Management terminal, patient terminal

The patient's state information may include not only parameters related to Parkinson's disease, but also various parameters such as information such as food ingested by the patient, exercise or sleep information of the patient, and exercise information related to changes in the surrounding environment.

For example, the management server 40, as described in Table 1, the various parameters included in the patient's status information, the drug information prescribed by the patient and the taking information of the drug, food or health food intake information ingested by the patient Includes drug information group, biometric information group that detects the patient's vital signs such as blood pressure, body temperature, heart rate, symptom information group that detects the pain, tremors, or symptoms of the patient, electroencephalogram, electrocardiogram, and electrocardiogram measured by the patient Autonomous nervous system including the EEG information group including, the gait information group to detect the walking state, including the patient's walking, rotation, and walking freezing information, the environmental information group to detect the movement state according to the change of the surrounding environment, the sleep time or sleep state Autonomic nerve information group that detects the information of exercise information, exercise information group including information on exercise time and non-exercise time due to illness in daily life, , Can be divided into diabetes patients with underlying diseases such as headache and cold or non-routine into a plurality of groups, or the like other diseases information group including information other diseases, including other diseases caused for.

For example, the gait information group may include gait information in which a patient detects a gait state including a gait cycle and a stride of daily life, rotation information for detecting a rotation state when walking, a change in the width of a road or an alley when walking. It may include walking freeze information for detecting a gait freeae state when a specific situation occurs, including.

The management server 40 gives priority to each divided group, analyzes and quantifies the inspection or detection information for each parameter, and quantifies each digitized information according to the priority given to maintain the patient in a stabilized state. The analyzed analysis information may be provided to the management terminal 30 and the patient terminal 50.

For example, the management server 40 may provide information and dosage information of drugs to be administered to the patient, relative potency information for each drug, prescription information including the time, frequency and dosage of the drugs prescribed to the patient, and prescription to the patient. Stored information and interaction with other drugs in addition to the prescribed drug and the drug, and interaction information between the prescribed drug and food or health functional food, and stores the stored information in the management terminal 30 and the patient terminal ( 50).

The drug information may include the name of each drug prescribed to the patient, the time and period of administration of each drug, daily dose and dose information.

The taking information of the drug is information on the actual patient taking the drug, and the user may check whether the corresponding drug is taken by touching the screen of the patient terminal 50 with respect to each piece of information included in the drug information.

The management server 40 may update each drug and related information in real time through communication with a drug information management server (not shown) managed by a government agency such as the Ministry of Food and Drug Safety.

Thus, the management server 40 may manage the dosage of drugs prescribed to the patient, ie, dopamine preparation, such as levodopa dose, to treat Parkinson's disease.

In addition, the management server 40, according to the prescribed medication, each of the patient according to the interaction information of the prescribed prescription drugs to treat other diseases of the patient, such as diabetes or hypertension, or non-daily diseases such as cold or abdominal pain You can be guided on how to take the drug or to prevent prescriptions.

In addition, the management server 40 may distinguish and guide the intake recommended food or health functional food and the intake prohibited food or health functional food according to the interaction information between the prescribed drug and the food or health functional food.

Accordingly, the doctor checks the change of each parameter included in the patient's state information, for example, the degree of disease change or other disease occurrence, and the management terminal 30 communicates with the management server 40 according to the doctor's operation. The priority given through communication can be changed.

In addition, the management terminal 30 may change the priority of each parameter according to the priority requested by the patient, such as relief of pain or symptoms.

On the other hand, in this embodiment, the management server 40 to give a basic priority, according to the priority given by the management terminal 30 to adjust the stimulation applied to the brain and nerves, and to control to change the priority Although described, the present invention is not necessarily limited thereto.

That is, the present invention can be changed to change the priority given to each parameter in the mobile terminal 50 and to adjust the brain and nerve stimulation according to the given priority.

In addition, the present invention can be modified to control the brain and nerve stimulation in accordance with the priority given by the management terminal 30 in the deep brain stimulation device 50 itself.

However, in order to prevent the risk of an accident that may occur when the patient directly controls the driving of the deep brain stimulator 10 using the patient terminal 50, the present invention uses the patient terminal 50. If the priority change request, the management server 40 and the management terminal 30 through the review process of the doctor only if approved, change the priority is configured to deliver to the deep brain stimulator 10 desirable.

The patient terminal 50 transmits detection information on some parameters among the parameters included in the patient's state information to the management server 40, and deep brain stimulation apparatus 10 according to the analysis information received from the management server 40. ) Controls the driving of the unit.

That is, the patient terminal 50 receives the medication information prescribed to the patient from the management server 40, and receives the dose information of the drug from the user (hereinafter referred to as the 'patient') including the patient or guardian deep brain stimulation Transmit to device 10.

And the patient terminal 50 receives the medication information and food or functional food information that the patient took to treat other diseases in addition to Parkinson's disease, the input information management server 40 and deep brain stimulation apparatus (10) ) Can be sent.

To this end, the patient terminal 50 is provided with a dedicated application for receiving the state information of the patient, and controls the operation of the deep brain stimulation apparatus 10, and provides a wireless communication function to be connected to a mobile communication network or a local area network. It can be provided with various terminal devices such as a smartphone, a tablet PC, a laptop computer having.

And the patient terminal 50 may be provided with a communication module (not shown) to enable communication with the deep brain stimulation apparatus 10 using a short range wireless communication technology such as Bluetooth.

In addition, the patient terminal 50 directly detects the blood pressure, temperature, heart rate of the patient, or a smart watch (smart watch) having a function of detecting each information, a smart band (smart band) for detecting the brain wave of the patient, etc. It may be communicatively connected to a smart device (not shown) having a.

In addition, the patient terminal 50 may be provided with a GPS module for generating the patient's motion information and a sensor 51 such as a three-axis gyro sensor.

Next, the configuration of the deep brain stimulation apparatus will be described in detail with reference to FIGS. 1 and 2.

FIG. 2 is an exploded view of the deep brain stimulation device shown in FIG. 1.

As shown in FIGS. 1 and 2, the deep brain stimulation apparatus 10 may charge the power received through the power receiver 11 and the power receiver 11 to receive the power transmitted from the power transmitter 20. The battery 12 and the stimulation unit 13 for stimulating the brain and nerves by using the power supplied from the battery 12.

And the deep brain stimulator 10 is a communication unit for communicating with the controller 14 and the management terminal 30 and the patient terminal 50 to control the driving of each device provided in the deep brain stimulator 10 in a wireless communication method ( 15) may be further included.

The power receiver 11 may be provided as an ultrasonic transducer that converts an ultrasonic signal transmitted from the power transmitter 20 into electrical energy and receives power.

To this end, the power receiver 11 may include a plurality of piezoelectric elements for changing the voltage of the electrical energy by the pressure of the ultrasonic signal.

The piezoelectric element may be manufactured using lead zirconate titanate (PZT), which is a solid solution of zirconate (PbZrO ₃ ) and titanate (PbTiO ₃ ), which are ceramic materials having piezoelectric and pyroelectric properties.

As shown in FIG. 2, the power receiver 11, the controller 14, the communicator 15, and the battery 12 are sequentially stacked in the case 80 along the up and down directions, and the The upper surface of the case 17 may be packaged and a matching layer 16 may be provided to match the power transmitter 20 with the acoustic impedance.

That is, the ultrasonic signal transmitted from the power transmitter 20 is transmitted to the power receiver 11 through a medium layer such as skin or blood of the human body.

The transmission efficiency of the electric power wirelessly transmitted between the power transmitter 20 and the power receiver 11 is characterized by the characteristics of the medium layer, that is, the material, the geometry, the transmission medium, and the attenuation of the medium layer. attenuation) and the distance between the power transmitter 20 and the power receiver 11.

Accordingly, the present invention minimizes the reflection loss of power transmitted to the power receiver 11 by using the material and geometry of the matching layer 16 provided in the power transmitter 20 and the power receiver 11, respectively. The power transmission efficiency can be improved.

The battery 12 may be provided as a rechargeable secondary battery.

The stimulator 13 uses an internal microcontroller (not shown), a stimulation circuit (not shown), and the stimulus to generate a specific stimulus waveform for stimulating the brain and nerves using the DC power supplied from the battery 12. It may include a plurality of electrodes for stimulating the brain and nerves in accordance with the stimulus waveform generated in the circuit.

Here, each electrode may be provided with a plurality of channels for transmitting a stimulus signal to the brain and nerves.

The internal microcontroller changes the current value, voltage value, and period of the stimulus signal for stimulating the brain and nerve according to the control signal of the controller 10, and adjusts the position and combination of the electrodes for stimulating the brain and the nerve among the plurality of electrodes. You can change it.

Some or all of the electrodes may function to detect a brain wave of a patient that is changed by drugs and brain and nerve stimulation taken by the patient.

As such, the detection signal sensing the brain wave at the electrode is transmitted to the controller 14.

The control unit 14 may be provided as a central control unit for controlling the driving of each device provided in the deep brain stimulation device (10).

The controller 14 may control the driving of the stimulator 13 to control a stimulus applied to the brain and nerves by executing a driving program stored in a memory (not shown).

In addition, the control unit 14 manages load information that detects a change in power load due to various factors such as skin thickness, hair growth rate, and blood flow change in the process of stimulating the brain and nerve through the communication unit 15. 30) may be controlled to transmit.

In particular, the control unit 14 may generate a control signal to adjust the stimulus applied to the brain and nerves in accordance with the control signal received from the management terminal 30 or the patient terminal 50 and the EEG detection signal detected at each electrode. .

Meanwhile, the deep brain stimulation apparatus 10 may further include a detector 18 capable of sensing the load information, and a detection signal output from the detector 18 may be transmitted to the controller 14.

In addition to the load information described above, the detection unit 18 detects a variety of information such as vital signs such as body temperature, blood pressure, heart rate, respiratory rate, temperature of the battery 12, and electroencephalogram. It may include a sensor.

Thus, the control unit 14 may control to adjust the stimulation signal for stimulating the brain and nerve by linking the taking information of the drug and the EEG detection signal and the detection information detected by the detection unit 18.

In addition, the control unit 14 may control to change or update the program driving the stimulation unit 13 according to a control signal received from the management terminal 30 through the communication unit 15.

Next, the control method of the deep brain stimulation apparatus control system according to a preferred embodiment of the present invention will be described in detail with reference to FIG.

3 is a flowchart illustrating a step-by-step control method of the deep brain stimulation apparatus control system according to an embodiment of the present invention.

In step S10 of FIG. 3, the controller 14 of the deep brain stimulation apparatus 10 controls the driving of the stimulator 13 to stimulate the brain and the nerve through a plurality of electrodes by executing a pre-stored driving program.

If communication with the management terminal 30 (or patient terminal 50) is connected through the communication unit 15 of the deep brain stimulation apparatus 10 in step S12, the management terminal 30 is informed from the management server 40 To give priority to all parameters.

In step S14, the test equipment 31 transmits the information of the patient's condition, such as blood pressure or body temperature, heart rate, electrocardiogram, electrocardiogram, and electroencephalogram of the patient, to the management terminal 30.

At this time, the smart sensor connected to the sensor 51 and the patient terminal 50 of the patient terminal 50 also detects vital sign information from the patient's state information and transmits it to the patient terminal 50, the patient terminal 50 ) May transmit the received detection information and the medication information input from the patient to the management server 40 and the management terminal 30 and the deep brain stimulation apparatus 10.

Then, the management terminal 30 performs a basic test on the patient's condition using vital sign information including blood pressure, body temperature, and heart rate among the received patient's state information (S16).

As a result of examining such vital sign information, if the patient is in a normal state, the management terminal 30 gives priority to all parameters through communication with the management server 40 (S18) and according to the assigned priority. The detection information and input information of each parameter are analyzed and digitized, and the numerical information is transmitted to the deep brain stimulator 10 to maintain the patient in a stabilized state (S20).

Then, the control unit 14 of the deep brain stimulation apparatus 10 receives the analysis results from the management terminal 30, and the stimulation unit to adjust the intensity and period of the stimulation applied to the brain and nerves in accordance with the received analysis results The drive of (13) is controlled (S22).

As described above, the present invention prioritizes each parameter included in the patient's state information, and adjusts the stimulus applied to the brain and nerves according to the given priority, thereby satisfying a predetermined reference value for the entire parameter. It can be controlled to keep the state in a stabilized state.

Meanwhile, in the process of adjusting the brain and nerve stimulation according to the state information of the patient, the controller 14 checks whether power is received from the power transmitter 20 using the ultrasonic wireless power transmission technology (S24).

If the test result of the step S24 is received, the power receiving unit 11 of the deep brain stimulation apparatus 10 receives the power to charge the battery 12 (S26).

Subsequently, the control unit 14 returns to step S10 or step S12 to supply the electric power charged in the battery 12 to each device, and controls to repeat the subsequent steps.

While repeatedly performing these processes, the management terminal 30 may change the priority according to the progress of the disease, the change of symptoms, the request of the patient, etc., and may adjust the stimulus applied to the brain and the nerve according to the changed priority.

Accordingly, the present invention can change the priority of each parameter according to the progress of the disease, the change of symptoms, the patient's request, etc., thereby alleviating the symptoms caused by the disease, improving the treatment effect, and maintaining the patient in a stabilized state. have.

As mentioned above, although the invention made by the present inventor was demonstrated concretely according to the said Example, this invention is not limited to the said Example and can be variously changed in the range which does not deviate from the summary.

In the above embodiment, the configuration of the deep brain stimulation apparatus in the implantable medical device in the body, but the present invention is implanted in the device to stimulate a specific part of the body to relieve or treat symptoms, such as a pacemaker used It may be modified to be applicable to various implantable medical devices such as artificial organs, cochlear implants, gastric stimulators, spinal cord stimulators, cardiac defibrillators, cardiac pacemakers, insulin pumps, and limbs.

In the above embodiment, the stimulation unit and the sensing unit are described as being provided at the same time. However, the present invention provides only the stimulation unit to stimulate the nerves by providing only the stimulation unit and the sensing unit, such as a BMI (Brain Machine Interface), thereby providing load information without stimulation. It may be changed to be applicable to medical devices that detect only biometric information.

In addition, in the above embodiment has been described as the power supply to the deep brain stimulation apparatus by transmitting power wirelessly using the ultrasonic wireless charging method, the present invention is not only an ultrasonic wireless charging method, but also electromagnetic wave or radio frequency method May be modified to provide power.

The present invention is applied to an implantable medical device control system and a control method technology for implanting in the body to stimulate a specific part of the body.

10: Deep Brain Stimulator
11: power receiver 21: piezoelectric element
12: battery 13: magnetic pole
14: control unit 15: communication unit
16: matching layer 17: case
18: detector
20: power transmitter
30: management terminal 31: inspection equipment
40: management server
50: patient terminal 51: detection sensor

Claims (7)

Implantable medical devices that implant into the body and stimulate certain areas of the body,
A management terminal for controlling the operation of the implantable medical device by performing communication with the implantable medical device in a wireless communication method;
A management server connected to the management terminal so as to communicate with the management terminal, to give priority to each parameter included in the patient's state information, to store and manage, and to provide the stored information;
The management terminal controls the implantable medical device to adjust the stimulus applied to a specific part of the body in the implantable medical device so as to satisfy a predetermined reference value for all parameters based on the priority given to the management terminal. Control system. The method of claim 1,
A power transmitter which transmits power to the implantable medical device in the body by a wireless power transmission method using ultrasound in vitro;
Receiving medication information prescribed to the patient through communication with the management terminal, and further detects the patient's taking information and the patient's status information and transmits the detection information to the implantable medical device and management server in the body further Including,
The management terminal controls the implantable medical device control system, characterized in that for controlling the operation of the implantable medical device based on the detection information and the inspection information received from the test equipment and the patient terminal connected to communicate. The method according to claim 1 or 2,
The management server divides the parameters included in the patient's status information into a plurality of groups, gives priority to each of the divided groups, analyzes and quantifies the inspection or detection information for each parameter, and assigns them to the assigned priorities. Provide analysis information analyzing the information digitized according to the management terminal,
And the management terminal controls to adjust the stimulus by the implantable medical device to maintain the patient in a stabilized state by using the analysis information provided by the management server. The method of claim 3,
The management terminal performs a basic test on the patient's condition using vital sign information including blood pressure, body temperature, and heart rate among the received patient's state information, and if the test result is normal, a stimulus applied to a specific part of the body Intra-body implantable medical device control system, characterized in that for controlling to regulate. (a) stimulating a specific part of the body by using the power transmitted by the wireless power transfer method from the external power transmitter in the implantable medical device,
(b) prioritizing, storing, and managing each parameter included in the patient's status information in the management server; and
(c) controlling, at the management terminal, to adjust the stimulus applied to a specific part of the body in the implantable medical device so as to satisfy a predetermined reference value for all parameters based on the priority given by the management server. The control method of the implantable medical device control system characterized in that the. The method of claim 5,
(d) in the management terminal, further comprising performing a basic test on the patient's condition using vital sign information including blood pressure, body temperature, and heart rate among the patient's state information. Control method of equipment control system. The method according to claim 5 or 6,
(e) changing the priority given through communication with the management server according to disease progression, symptom change, and patient's request at the management terminal; Control method of control system.

Images